Search on Site

Explore our comprehensive database of pharmaceutical news releases, press releases, events, and industry insights with ease. Effortlessly find relevant information tailored to your interests and stay updated on the latest developments in the pharmaceutical sector. Start searching now to uncover valuable insights and resources for your pharmaceutical endeavors.

West introduces Daikyo PLASCAP® RUV closures in a new nested format at Pharmapack

high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of life-saving and life-enhancing medicines for patients. With over...

Artax Biopharma validates AX-158, a first-in-class oral Nck modulator, in phase 2a for autoimmune disease

we see great potential to address the treatment gap for patients." Given the broad effect of Nck modulation across all T helper cell populations (Th17, Th1/0 and Th2) in pre-clinical and animal models, the team is planning further studies in...

SeoulTech researchers unveil a novel approach to understanding PFOS-induced neurotoxicity, advancing environmental health studies

lipids and metabolites compared to the conventionally used extraction solvents. Application of the MTBE-based strategy helped record the changes in metabolites and lipids linked to energy metabolism in PFOS-exposed zebrafish larvae. "The disruption...

NTx announces the full commercial availability of NTxscribe to broadly enable RNA therapies

academic medical centers and major biopharma organizations, we are excited to bring NTxscribe to the broader market and help unlock the full potential of RNA therapies by enabling innovation for the future of medicine.” About NTx: Nature’s Toolbox,...

Dr. Alastair Leighton, a biopharma veteran, has been hired as Chief Operating Officer by Chemify

in manufacturing, supply chain operations and commercial strategy. “I’m excited to welcome Alastair to Chemify to help us with building and scaling our ability to make complex molecules on demand at scale for our partners using Chemputation,” said...

Cardurion Pharmaceuticals has named Charlotte Newman as Chief Business Officer

be responsible for leading corporate development, business development, portfolio strategy and new product planning to help Cardurion maximize opportunities for its growing portfolio of cardiovascular drug candidates. “We are delighted to welcome...

PBS Biotech Secures $17M and Expands Leadership to Accelerate Next-Gen Cell Therapies

innovation, process development services, and quality system improvements, further advancing the cell therapy industry and helping their customers bring life-saving therapies to market faster. The company is also expanding its ISO 9001:2015...

"Fresenius Kabi expands its U.S. pharma portfolio with the launch of Epinephrine Injection, USP

supporting blood banks and health care facilities worldwide. The company’s I.V. Generics and Fluids for infusion therapy help save millions of lives every year, in emergency medicine, surgery, oncology, and intensive care. Fresenius Kabi takes a...

UroMems Appoints Former Axonics Executive Rinda Sama to Board of Directors

for more than 10 years where he played a critical role in implementing lean operations and compliant quality systems that helped to pave the way for Food and Drug Administration (FDA) approval and the recent acquisition of Axonics by Boston...

Children’s Hospital Los Angeles completes its 100th retinal gene therapy procedure, advancing pediatric vision care.

emphasis here has always been on treating kids as early as possible so we can give that tool back to these ‘factories’ and help children maintain their vision over the course of their lifetime. How does Luxturna gene therapy work? Gene therapies...

Dr. Jonathan Sadeh, ex-SVP of Immunology R&D at Bristol-Myers Squibb, joins Scinai Immunotherapeutics' Scientific Advisory Board

Planck and UMG further strengthens my belief in Scinai's potential. I look forward to contributing to Scinai's mission and helping establish it as a globally recognized leader in scientifically driven drug development". Amir Reichman, CEO of...

Neurophet gains FDA 510(k) clearance for Neurophet AQUA, advancing multiple sclerosis analysis with AI-driven precision

software for electric and magnetic brain stimulation "Neurophet tES/TMS LAB". Neurophet has set its top priority to helping patients suffering from brain diseases. Based on expertise in neuroscience, Neurophet will continue to challenge and grow to...

Automated red blood cell exchange boosts quality of life for sickle cell patients

Antoinette Gawin, President and CEO of Terumo BCT. "Exchange therapies remain a mainstay to avoid disease complications, helping these warriors live their lives. We continue partnering with patient advocacy and policy groups to expand access to...

Preclinical study shows NUZ-001 reduces TDP-43 aggregation in ALS

offices, and staff throughout Europe and North America. Ncardia is built on the belief that stem cell technology will help bring better therapies to patients faster. The company's goal is to enable biopharmaceutical companies in drug discovery to...

Bracco Diagnostics Inc. reaches one million injections milestone with its MRI agent, VUEWAY® (gadopiclenol)

has reached over one million patient injections at over 480 customer sites. This hallmark achievement is significant as it helped address the unmet medical need to minimize gadolinium (Gd) exposure per MRI procedure without compromising image...

GoodRx debuts a new e-commerce platform, starting with Opill®

leverage our platform’s reach to expand market presence, increase consumer access to essential medications and ultimately help drive growth." The GoodRx and Opill partnership addresses significant gaps in healthcare access, particularly for the...

Great Bay Bio launches its Intelligent Drug Development Ecosystem

to culture media development and optimization, etc., giving revolutionary changes to biopharmaceutical development, helping customers develop products faster and better. Mr. Kingsley Leung, co-founder and chairman of GBB, said: "I am very happy to...

ARTHEx Biotech doses first patient in Phase I-IIa ArthemiR™ trial for Myotonic Dystrophy Type 1

like ATX-01 may be critical for patients, families and the broader community to gain additional knowledge which may help lead to better clinical outcomes and possibly an approved treatment. I am excited to evaluate ATX-01's dual mechanism of action...

The U.S. FDA provides positive guidance on the Phase III trial of 64Cu-SAR-bisPSMA for recurrent prostate cancer.

data that we have seen in our trials with 64Cu-SAR-bisPSMA to date. We believe that better diagnostic tools will help clinicians determine the best course of treatment for their patients, and our team and collaborators look forward to bringing this...

BioCare collaborates with AeroSafe Global to introduce sustainable cold chain solutions

"Our cold chain service program provides the most advanced thermal packaging solutions while reducing waste and emissions, helping create a more sustainable future." About AeroSafe Global: AeroSafe Global is a leader in biopharmaceutical cold chain...